retatrutide and menopause for Weight Gain: Complete 2026 Guide Retatrutide for Women: Safety, Results

Several other indications are under study, including obstructive sleep apnea, MASLD, knee osteoarthritis, chronic kidney disease, and cardiovascular outcomes

Your provider monitors your response and adjusts dosing through regular virtual check-ins

These entities, often referred to as health technology assessments (HTA) agencies conduct systematic evaluations of new medical technologies to guide reimbursement decisions

Evidence so far demonstrates that GLP-1 agonists can produce unprecedented results for people trying to achieve weight loss, in some cases enabling patients to lose 15-20% of their body weighttwo to three times the amount achieved with previous medications